Shreveport, LA3 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Shreveport, LA

Find 3 actively recruiting myalgic encephalomyelitis clinical trials in Shreveport, LA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
702
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Shreveport

About Myalgic Encephalomyelitis Clinical Trials in Shreveport

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 3 myalgic encephalomyelitis clinical trials recruiting participants in Shreveport, LA. These studies are seeking a combined 702 participants. Research is being sponsored by Genmab, Annexon, Inc., National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Shreveport — FAQ

Are there myalgic encephalomyelitis clinical trials in Shreveport?

Yes, there are 3 myalgic encephalomyelitis clinical trials currently recruiting in Shreveport, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Shreveport?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Shreveport research site will contact you about next steps.

Are clinical trials in Shreveport free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Shreveport studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 3 active trials in Shreveport are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov